BODY PHARM WINSTROL 10
BODY PHARM WINSTROL TABS(10MG STANOZOLOL/TAB=50TABS)
Active-Life: About 8 hours
Drug Class: Anabolic/Androgenic steroid (Oral)
Average Reported Dosage: Males 20-50-mg daily Women 10-15-mg daily
Water Retention: Rare
High Blood Pressure: Rare
Liver Toxic: High in high oral dosages
DHT Conversion: None, DHT derivative
Decreases HPTA Function: Low
Pretty much everything written thus far about Stanozolol injectable (*See "Winstrol Depot" under "Injectable Anabolic Androgenic Steroids" for more info) was also attributed also to the oral form. It was often said that the oral form is less effective than the injectable. In truth, it was usually due to dosages, and this in turn was due to price. Athletes usually administered a lower dosage orally because it seemed like 25 pills daily was mega dosing. In my personal opinion this was true to a point. Oral use of any 17-alfa-alkylated steroid is hard on the liver. This is because it is difficult for the liver to deactivate these modified testosterone and derivatives. Let me make it clear. Milligram for milligram oral administration of Stanozolol was reported significantly more potent than the injection product (but it is more liver toxic). Oral dosages were commonly broken into 2-3 daily dosages to maintain circulatory androgen elevation. An effective reported daily oral dosage for women was 10-15mg and for men 20-30. However, this listed male dosage was not as effective (or as toxic) as the 30-50mg daily dose range.
Male athletes reported the practice of stacking 40-50mg of Stanozolol daily with 300-400mg weekly of a nandrolone provided significant lean muscle tissue augmentation with good post-cycle retention. For "bulking" purposes many reported the use of this drug with a testosterone at an average reported dosage of 200-600mg weekly resulted in "amazing strength and weight gains" and improved post-cycle lean mass retention.
Women athletes commonly reported the use of Stanozolol at a dosage of 10-15mg daily with 50-100mg of a nandrolone weekly resulted in a rapid increase in quality lean mass tissue with low water retention and rare virilizing negative side effects.
Anabolic steroids such as Stanozolol are synthetic derivatives of the male hormone testosterone. Stanozolol has a pronounced anabolic effect with fewer masculinizing side effects than testosterone and some other synthetic anabolic steroids. Anabolic steroids are used in stimulating appetite and increasing weight gain, strength, and vigor. They should be used as a part of an overall program with other supportive and nutritional therapies.
This is a very popular anabolic steroid, which is a derivative of dihydrotestosterone. Winstrol is a relatively low androgenic steroid which will not aromatise. It is moderately toxic to the liver. Very few users report any water retention or any other side effects while using Winstrol. It is a popular drug for cutting in a stack with Primobolan or Parabolan. When stacked with Testosterone it can be very effective for a size and strength gain. Women use the drug quite often, but it can cause virilising effects for some women even at low dosages. Most of the muscle gains made while taking the Winstrol are retained after the drug is discontinued. The injectable form is better than the oral. Many feel that the injectable must be administered at least twice a week: some take shots every day for better effects. Dosages range from 3 to 5 cc?s per week for men, 1 to 2 cc's in women. .
Stanozolol is prescribed for chronic infections, for conditions such as extensive surgery, [corticosteroid-induced myopathy, decubitus ulcers, burns] , or severe trauma, which require reversal of catabolic processes or protein-sparing effects. This is used in addition to, and not as replacements for, conventional treatment of these disorders.
Stanozolol is effective in raising hemoglobin concentrations in some cases of aplastic anemia (congenital or idiopathic).
Stanozolol is indicated in the prophylaxis of hereditary angioedema to decrease the frequency and severity of attacks.
Stanozolol is used in the treatment of hereditary angioedema.
Stanozolol is indicated in the treatment of conditions associated with decreased fibrinolytic activity due to antithrombin III deficiency or excess fibrinogen. These conditions may include cutaneous vasculitis, scleroderma of Raynaud's disease, vasculitis of Behcet's disease, and complications of deep vein thrombosis such as venous lipodermatosclerosis. Stanozolol is indicated in the prevention of recurrent venous thrombosis associated with antithrombin III deficiency. Stanozolol may be of benefit in patients susceptible to or with a history of thromboembolism for the treatment of vascular disorders associated with these forms of reduced fibrinolytic activity.